Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SafeCoat Medical develops a proprietary antimicrobial peptide-based coating for medical devices and implants that repels and kills bacteria, preventing biofilm formation and device-associated infections. The platform is substrate-independent, stable, and demonstrates broad-spectrum antibiofilm and antifouling activity in animal models. The coating has shown >1000-fold reduction in bacterial load in preclinical models, with no loss of activity under harsh conditions or long-term storage. The technology is based on a combination of antifouling self-assembling polymers and conjugated antimicrobial peptides, is biocompatible, and can be applied to a wide variety of materials via dipping or spraying[6].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SafeCoat Medical.